Patent foramen ovale post-surgical follow up

Revision as of 16:43, 9 September 2011 by Priyamvada Singh (talk | contribs) (New page: {{Patent foramen ovale}} {{CMG}}; '''Associate Editors-In-Chief:''' Priyamvada Singh, M.B.B.S. [mailto:psingh@perfuse.org]; '''Assistant Editor-In-Chief:''' [[Kristin...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Patent Foramen Ovale Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Patent Foramen Ovale from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

PFO and Stroke

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Patent foramen ovale post-surgical follow up On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Patent foramen ovale post-surgical follow up

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Patent foramen ovale post-surgical follow up

CDC on Patent foramen ovale post-surgical follow up

Patent foramen ovale post-surgical follow up in the news

Blogs on Patent foramen ovale post-surgical follow up

Directions to Hospitals Treating Patent foramen ovale

Risk calculators and risk factors for Patent foramen ovale post-surgical follow up

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [3]

Aspirin or warfarin should be continued for 6 months after percutaneous closure of patent foramen ovale

References

See also


Template:WikiDoc Sources